Safety and Efficacy of Etrasimod (APD334) in Patients With Ulcerative Colitis
Clinical trial NCT02447302 · COMPLETED
Trial details
- NCT number
- NCT02447302
- Sponsor
- Arena Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-15
- Primary completion
- 2018-02-14
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.